This COVID-19 roundup includes coverage of the FDA’s amendment to its emergency use authorization of the Pfizer-BioNTech booster for pediatric patients, acute myocardial infection deaths rose during omicron...
Among those with statin-intolerance, bempedoic acid, an inhibitor used to decrease elevated levels of low-density lipoprotein cholesterol, was also associated with a lower risk of major adverse...
Did you watch our Multidisciplinary Roundtable on the current challenges and opportunities in digital health innovation for managing patients with heart failure with reduced ejection fraction? Here are some...
The researchers evaluated the effects of two medications used for type 2 diabetes patients on reducing major cardiovascular events in both men and women.
The American Heart Association (AHA) addresses the adverse effect of hypertension in patients receiving anticancer therapies and how the disease should be managed.
The American Heart Association (AHA) released a statement regarding the use of complementary and alternative treatments that are used in the United States for the treatment of heart failure symptoms.
This COVID-19 roundup includes coverage on vaccine safety for older adults, the efficacy of fluvoxamine on COVID-19 symptoms, the use of convalescent plasma transfusion in immunocompromised patients, and...
The American Heart Association (AHA) statement recommends strategies for clinicians on how they can manage acute coronary syndrome in the older adult population.
In a recent study, researchers evaluated the burden of left ventricular diastolic dysfunction (LVDD) and heart failure with preserved ejection fraction (HFpEF) in systemic sclerosis (SSc) and determined the...
In a recent study, researchers examined the efficacy and impact of various direct oral anticoagulants on multiple health outcomes in individuals with atrial fibrillation.
